JOURNAL OF VASCULAR SURGERY. Retrograde stenting of proximal lesions with carotid endarterectomy increases risk

W. Darrin Clouse, MD, Emel A. Ergul, MS, Richard P. Cambria, MD, David C. Brewster, MD, Christopher J. Kwolek, MD, Glenn M. LaMuraglia, MD, Virendra I. Patel, MD, MPH, Mark F. Conrad, MD, MMSc

Objective: Concomitant carotid bifurcation and proximal ipsilateral arch branch disease is uncommon. A combined approach using carotid endarterectomy (CEA) with ipsilateral proximal endovascular (IPE) intervention (CEA+IPE) has been proposed as safe and durable, with similar results to isolated CEA. This study was conducted to identify diagnostic modalities and outcomes of this uncommon procedure at our institution.

JOURNAL OF VASCULAR SURGERY. Outcomes after carotid artery stenting in hemodialysis patients

Isibor J. Arhuidese, MD, MPH, Tammam Obeid, MD, Caitlin W. Hicks, MD, MS, Kanhua Yin, MD, Joseph Canner, MHS, Dorry Segev, MD, PhD, Mahmoud B. Malas, MD, MHS

Background: Patients who require hemodialysis are historically excluded from randomized studies of carotid artery stenting (CAS) due to perceived poor outcomes. Observational studies of outcomes after CAS in hemodialysis patients are mostly limited to small, single-institution series.

JOURNAL OF VASCULAR SURGERY. International experience with endovascular therapy of the ascending aorta with a dedicated endograft

Nikolaos Tsilimparis, MD, PhD, E. Sebastian Debus, MD, PhD, Gustavo S. Oderich, MD, Stephan Haulon, MD, Kim Allan Terp, MD, Blayne Roeder, Christian Detter, MD, PhD, Tilo Kölbel, MD, PhD

Objective: The objective of this study was to evaluate the safety and feasibility of a novel stent graft specifically designed for treatment of the ascending aorta.

JOURNAL OF VASCULAR SURGERY. Worldwide results from the RESTORE II on elective endografting of thoracic aneurysms and dissections

Burkhart Zipfel, PhD, Patricio Zaefferer, MD, Vicenç Riambau, MD, PhD, Zoltán Szeberin, PhD, Ernst Weigang, MD, Marcelo Menéndez, MD, Martin Funovics, MD, Mohamad Hamady, MD on behalf of the show RESTORE II Study Group

Objective: To assess safety, performance, and efficacy of the RELAY thoracic stent graft (Bolton Medical, Barcelona, Spain) in the treatment of patients who require elective thoracic endovascular aortic repair including aneurysms and dissections.

JOURNAL OF VASCULAR SURGERY. Intraoperative neuroprotective interventions prevent spinal cord ischemia and injury in thoracic endovascular aortic repair

Charles Acher, MD, MPH, C.W. Acher, MD, Erich Marks, MD, Martha Wynn, MD

Objective: Transient and permanent paraparesis and paraplegia (spinal cord injury [SCI]) are reported in up to 13% of patients undergoing thoracic endovascular aortic repair (TEVAR) for descending thoracic aortic aneurysm, thoracoabdominal aortic aneurysm, and thoracic aortic dissection. We hypothesize that aggressive intraoperative and postoperative neuroprotective interventions prevent or significantly reduce all SCI in TEVAR.

JOURNAL OF VASCULAR SURGERY. The impact of concomitant procedures during endovascular abdominal aortic aneurysm repair on perioperative outcomes

Klaas H.J. Ultee, BSc, Sara L. Zettervall, MD, Peter A. Soden, MD, Jeremy Darling, BA, Jeffrey J. Siracuse, MD, Matthew J. Alef, MD, Hence J.M. Verhagen, MD, PhD, Marc L. Schermerhorn, MD on behalf of the Vascular Study Group of New England

Background: Concomitant procedures during endovascular aneurysm repair (EVAR) of an abdominal aortic aneurysm are performed to facilitate endograft delivery, to simultaneously treat unrelated conditions, or to resolve intraoperative pitfalls. The frequency and perioperative impact of these procedures are not well described. This study aimed to assess the frequency and perioperative impact of various concomitant procedures performed at the time of EVAR.

JOURNAL OF VASCULAR SURGERY. Outcomes of patients with type I endoleak at completion of endovascular abdominal aneurysm repair

Tze-Woei Tan, MD, Mohammed Eslami, MD, Denis Rybin, PhD, Gheorghe Doros, PhD, Wayne W. Zhang, MD, Alik Farber, MD

Background: Type I endoleak (TIE) during endovascular aneurysm repair (EVAR) is usually identified and treated intraoperatively. We evaluated the outcomes of patients who, despite possible treatment, had TIE at completion of EVAR.

JOURNAL OF VASCULAR SURGERY. Predicting reinterventions after open and endovascular aneurysm repair using the St George´s Vascular Institute score

Jorg Lucas de Bruin, MD, Alan Karthikesalingam, PhD, Peter J. Holt, PhD, Monique Prinssen, PhD, Matt M. Thompson, MD, Jan D. Blankensteijn

Background: Identifying patients at risk for aneurysm rupture and sac expansion after open and endovascular abdominal aortic aneurysm (AAA) repair (EVAR) may help to attenuate this risk by intensifying follow-up and early detection of problems. The goal of this study was to validate the St George´s Vascular Institute (SGVI) score to identify patients at risk for a secondary intervention after elective aneurysm repair.

JOURNAL OF VASCULAR SURGERY. Experience with the GORE EXCLUDER iliac branch endoprosthesis for common iliac artery aneurysms

Steven M.M. van Sterkenburg, MD, Jan M.M. Heyligers, MD, PhD, Mathijs van Bladel, BSc, Hence J. Verhagen, MD, PhD, Daniël Eefting, MD, PhD, Marc R. van Sambeek, MD, PhD, Clark J. Zeebregts, MD, PhD, Michel M.P.J. Reijnen, MD, PhD for the Dutch IBE Collaboration

Objective: In this study, we analyzed the procedural success and early outcome of endovascular treatment of a multicenter cohort of patients with common iliac artery (CIA) aneurysms treated with the new GORE EXCLUDER (W. L. Gore & Associates, Flagstaff, Ariz) iliac branch endoprosthesis (IBE).

JOURNAL OF VASCULAR SURGERY. Chronic mesenteric ischemia outcome analysis and predictors of endovascular failure

Nikolaos Zacharias, MD, Sammy D. Eghbalieh, MD, Benjamin B. Chang, MD, Paul B. Kreienberg, MD, Sean P. Roddy, MD, John B. Taggert, MD, Yaron Sternbach, MD, R. Clement Darling III, MD

Objective: Outcomes of open revascularization (OR) and endovascular revascularization (ER) for chronic mesenteric ischemia (CMI) were analyzed to identify predictors of endovascular failure.

JACC: CARDIOVASCULAR INTERVENTIONS. Predictors for Successful Endovascular Intervention in Chronic Carotid Artery Total Occlusion

Ying-Hsien Chen, MDa; Weng-San Leong, MDb; Mao-Shin Lin, MDa,c; Ching-Chang Huang, MDa; Chi-Sheng Hung, MDa; Hung-Yuan Li, MDa; Kok-Kheng Chan, MDd; Chih-Fan Yeh, MDa; Ming-Jang Chiu, MD, PhDe; Hsien-Li Kao, MDa

Objectives: This study sought to determine predictors for successful endovascular treatment in patients with chronic carotid artery occlusion (CAO).

JACC: CARDIOVASCULAR INTERVENTIONS. Elimination of Transcoarctation Pressure Gradients Has No Impact on Left Ventricular Function or Aortic Shear Stress After Intervention in Patients With Mild Coarctation

Zahra Keshavarz-Motamed, PhDa; Farhad Rikhtegar Nezami, PhDa; Ramon A. Partida, MDa,b; Kenta Nakamura, MDa,b; Pedro Vinícius Staziaki, MDb; Eyal Ben-Assa, MDa; Brian Ghoshhajra, MDb; Ami B. Bhatt, MDb; Elazer R. Edelman, MD, PhDa,c

Objectives: This study sought to investigate the impact of transcatheter intervention on left ventricular function and aortic hemodynamics in patients with mild coarctation of the aorta (COA).

JACC: CARDIOVASCULAR INTERVENTIONS. Acotec Drug-Coated Balloon Catheter. Randomized, Multicenter, Controlled Clinical Study in Femoropopliteal Arteries: Evidence From the AcoArt I Trial

Xin Jia, MDa; Jiwei Zhang, MDb; Baixi Zhuang, MDc; Weiguo Fu, MDd; Danming Wu, MDe; Feng Wang, MDf; Yu Zhao, MDg; Pingfan Guo, MDh; Wei Bi, MDi; Shenming Wang, MDj; Wei Guo, MDa

Objectives: The aim of this study was to investigate the efficacy and safety of a new paclitaxel-coated balloon catheter in the treatment of stenotic or occluded femoropopliteal arteries.

JACC: CARDIOVASCULAR INTERVENTIONS. Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease. An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials

Daniele Giacoppo, MDa; Salvatore Cassese, MD, PhDa; Yukinori Harada, MDa; Roisin Colleran, MBChBa; Jonathan Michel, MBBSa; Massimiliano Fusaro, MDa; Adnan Kastrati, MDa,b; Robert A. Byrne, MBChB, PhDa

Objectives: This study sought to assess the risk of target lesion revascularization (TLR) and all-cause death at 12 months and at the maximum available follow-up. Secondary objectives included the identification of factors which could have influenced general findings.

JACC: CARDIOVASCULAR INTERVENTIONS. Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Arteries Below the Knee. 12-Month Clinical and Imaging Outcomes

Ramon L. Varcoe, MBBS, MS, PhDa,b,c; Olaf Schouten, MD, PhDa,d; Shannon D. Thomas, BSc Med Hons, MBBSa,b,c; Andrew F. Lennox, MBBS, MSca,c

Objectives: The aim of this study was to investigate the midterm performance of an everolimus-eluting, bioresorbable vascular scaffold (Absorb, Abbott Vascular, Santa Clara, California) for the treatment of focal tibial and distal popliteal lesions.